Johnny John
Insider Reports History
- Location
- New York, NY
- Signature
- /s/ Gerard Michel, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Johnny John:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DELCATH SYSTEMS, INC. | SVP CLINICAL DEV & MED AFFAIRS | Stock Option (Right to Buy) | 46,800 | 08 Feb 2023 | Direct |
Insider Reports Filed by Johnny John
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DCTH | DELCATH SYSTEMS, INC. | 12 Jun 2023 | 1 | $0 | 4 | Senior Vice President Clinical Development and Medical Affairs | 21 Jun 2023, 21:16 |
| DCTH | DELCATH SYSTEMS, INC. | 08 Feb 2023 | 1 | $0 | 4 | SVP CLINICAL DEV & MED AFFAIRS | 26 Jan 2024, 16:22 |
| DCTH | DELCATH SYSTEMS, INC. | 04 Apr 2022 | 0 | $0 | 3/A | Senior Vice President Clinical Development and Medical Affairs | 15 Aug 2022, 12:06 |